Pulmonx LUNG
NASDAQ LUNG
$1.96 -0.02 (-1.26%)
As of: Sep 30, 2026 · 3:42 PM EDT

Pulmonx (LUNG) EBITDA Margin (2019 - 2025)

Updated

Pulmonx (LUNG) posted EBITDA Margin of -65.79% for Q3 2025, up 1.67 percentage points from -67.46% a year earlier but down 5.00 percentage points from the prior quarter.

Analysis

Pulmonx (LUNG) EBITDA Margin (2019 - 2025) Analysis & Trends

For the trailing twelve months through Sep 30, 2025, EBITDA Margin at Pulmonx was -61.16%, up 10.37 percentage points year-over-year; for FY2024, it was -67.09%, up 20.85 percentage points from FY2023.

  • Annual EBITDA Margin shows a five-year change of -13.48 percentage points (FY2019 to FY2024).
  • In prior years, Pulmonx's EBITDA Margin was -87.93% in FY2023 (+18.52 pp), -106.45% in FY2022 (-10.54 pp), -95.91% in FY2021 (+1.39 pp) and -97.30% in FY2020 (-43.69 pp).
  • Quarterly EBITDA Margin has run from a low of -141.86% in Q1 2022 to a high of -55.22% in Q4 2024 over five years.
  • On a year-over-year basis, EBITDA Margin has increased in each of the last 11 quarters, with an average year-over-year change of +16.72 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for EBITDA Margin in the past five years was Q2 2021, with a gain of 207.89 percentage points; the weakest was Q1 2021, with a drop of 64.15 percentage points.
  • According to Business Quant data, EBITDA Margin for the three prior quarters was -60.79% (Q2 2025), -63.38% (Q1 2025) and -55.22% (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 24.20%
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 21.86%
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 28.51%
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn 41.08%
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 25.55%
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 29.67%
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 28.17%
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 31.93%
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 24.62%
10 Pulmonx 82.51 Mn -236.71 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -65.79%
Jun 30, 2025 -60.79%
Mar 31, 2025 -63.38%
Dec 31, 2024 -55.22%
Sep 30, 2024 -67.46%
Jun 30, 2024 -73.24%
Mar 31, 2024 -74.85%
Dec 31, 2023 -70.71%
Sep 30, 2023 -83.55%
Jun 30, 2023 -93.23%
Mar 31, 2023 -109.82%
Dec 31, 2022 -92.32%
Sep 30, 2022 -100.34%
Jun 30, 2022 -100.61%
Mar 31, 2022 -141.86%
Dec 31, 2021 -87.48%
Sep 30, 2021 -72.06%
Jun 30, 2021 -102.73%
Mar 31, 2021 -133.63%
Dec 31, 2020 -93.86%
API Access

Pulmonx EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=LUNG&period=max&api_key=YOUR_API_KEY